Refining Safe Contrast Limits for Preventing Acute Kidney Injury After Percutaneous Coronary Intervention
Background Contrast‐associated acute kidney injury (CA‐AKI) is associated with substantial morbidity and may be prevented by using less contrast during percutaneous coronary intervention (PCI). However, tools for determining safe contrast volumes are limited. We developed risk models to tailor safe...
Main Authors: | Neal Yuan, Khalid Latif, Patrick G. Botting, Yaron Elad, Steven M. Bradley, Teryl K. Nuckols, Susan Cheng, Joseph E. Ebinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.018890 |
Similar Items
-
Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
by: Ata Firouzi, et al.
Published: (2018-09-01) -
Incidence, Risk Factors, and Outcomes of Contrast Associated Nephropathy following Percutaneous Coronary Intervention
by: Iqbal Wani, et al.
Published: (2020-01-01) -
Intravascular Imaging in Ultra-Low or Zero-Contrast Percutaneous Coronary Interventions: The Time Is Now?
by: Kyriakos Dimitriadis, et al.
Published: (2023-12-01) -
Contrast-induced nephropathy; A literature review
by: Jafar Golshahi, et al.
Published: (2014-04-01) -
Prevalence of contrast-induced nephropathy after primary percutaneous coronary intervention at a tertiary referral hospital
by: Zahra Masoomi, et al.
Published: (2024-02-01)